Trademark Search  /  I-RESPOND EVALUATION OF IRBESARTAN (WITH OR WITHOUT HCTZ) IN IMPROVING INSULIN SENSITIVITY IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME

I-RESPOND EVALUATION OF IRBESARTAN (WITH OR WITHOUT HCTZ) IN IMPROVING INSULIN SENSITIVITY IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME

○ Dead · Cancelled

U.S. federal trademark · Serial No. 78902550 · Reg. No. 063430504

Mark
I-RESPOND EVALUATION OF IRBESARTAN (WITH OR WITHOUT HCTZ) IN IMPROVING INSULIN SENSITIVITY IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME
Status
Cancelled
Serial Number
78902550
Registration No.
063430504
Filing Date
May 23, 2006
Registration Date
May 23, 2006
Class(es)
Class 042

Owners

SANOFI
99 · Paris, FR
sanofi-aventis
99 · Paris, FR
sanofi-aventis
99 · Paris, FR
sanofi-aventis
99 · Paris, FR

Goods & Services

Clinical research in the field of hypertension and anti-hypertensive pharmaceuticals; medical and scientific research, namely, conducting clinical trials for anti-hypertensive pharmaceuticals

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "I-RESPOND EVALUATION OF IRBESARTAN (WITH OR WITHOUT HCTZ) IN IMPROVING INSULIN SENSITIVITY IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.